Background: Lactate is associated with morbidity and mortality; however, the value of prehospital lactate (pLA) is unknown. Our objective was to determine whether pLA improves identification of mortality and morbidity independent of vital signs. Methods: We measured pLA in 1,168 patients transported by rotorcraft to a Level I trauma center over 18 months. The primary outcome was in-hospital mortality; secondary outcomes were emergent surgery and multiple organ dysfunction syndrome (MODS). Covariates include age, sex, prehospital vital signs, and mental status. We created multivariable logistic regression models and tested them for interaction terms and goodness of fit. Cutoff values were established for reporting operating characteristics using shock (defined as shock index Ͼ0.8, heart rate Ͼ110, and systolic blood pressure Ͻ100), tachypnea (RR Ն30), and altered sensorium (Glasgow Coma Scale score Ͻ15). Results: In-hospital mortality was 5.6%, 7.4% required surgery and 5.7% developed MODS. Median lactate was 2.4 mmol/L. Lactate was associated with mortality (odds ratio [OR], 1.23; p Ͻ 0.0001), surgery (OR, 1.13; p Ͻ 0.001), and MODS (OR, 1.14; p Ͻ 0.0001). Inclusion of pLA into a logistic model significantly improved the area under the receiver operator curves from 0.85 to 0.89 for death (p Ͻ 0.001), 0.68 to 0.71 for surgery (p ϭ 0.02), and 0.78 to 0.81 for MODS (p ϭ 0.002). When a threshold lactate value of Ͼ2 mmol/L was added to a predictive model of shock, respiratory distress, or altered sensorium, it improved sensitivity from 88% to 97% for death, 64% to 86% for surgery, and 94% to 99% for MODS.
T raditional trauma triage uses physiologic variables, including vital signs, which often do not predict need for surgical resources or outcomes. 1, 2 Blood pressure and heart rate may change later in shock when compensatory mechanisms fail in hemorrhagic shock. Compensated shock is not easily recognizable by prehospital providers. [2] [3] [4] [5] [6] Delayed identification of hypoperfusion may lead to triage of some patients away from specialized trauma centers and to inadequate or delayed resuscitation, which is strongly associated with increase in infection, multiple organ dysfunction (MOD), and mortality. 3, 7, 8 Serum lactate is a byproduct of anaerobic metabolism, is a circulating biomarker of organ oxygen supply/demand mismatch, and is directly related to mortality in patients with sepsis, myocardial infarction, and trauma. 9, 10 Trends in serum lactate levels can also monitor the effectiveness of resuscitation, even in patients with normal vital signs. 10, 11 Currently, technological advances have led to the production of handheld, point of care (POC) lactate analyzers that produce fast, reliable, and valid measurements. 12 Use of POC lactate is now feasible in the out-of-hospital setting, but the additional value of prehospital lactate (pLA) for predicting in-hospital outcomes is unknown.
Importance
If increased pLA identifies patients who go on to have clinically significant outcomes after trauma, then it may assist prehospital triage by directing transport to regionalized trauma centers for more aggressive early resuscitation. If pLA improves identification of outcomes independent of clinically available prehospital variables, then it could be especially useful to risk stratify patients who do not show any initial signs of physiologic perturbation. Ultimately, protocols designed to intervene with earlier resuscitation based on pLA may have a protective effect in trauma-associated mortality.
Goals of This Investigation
This study sought to determine the additional value of pLA as a biomarker for mortality and morbidity in patients presenting to prehospital providers with acute trauma. We investigated the odds ratios of in-hospital outcomes in patients with increased pLA compared with and adjusting for traditional covariates using multivariable logistic regression models. We then explored the improved sensitivity of identifying outcomes when pLA above a threshold of 2 mmol/L was added to other traditional prehospital markers of shock, respiratory distress, and altered sensorium. Our air medical service has 21 helicopters, 17 bases, and covers a four-state region. The emergency department (ED), with 50,000 annual visits, serves an urban, academic teaching hospital with 700 beds and is a Level I trauma center with Ͼ5,000 trauma admissions a year. Air medical patients represent 30% of trauma admissions in our facility due to the geography of our catchment area.
Selection of Participants
The study inclusion criteria were age 18 years or older, serum lactate level obtained by prehospital providers, and admission to the hospital. All trauma patients transported by air during this time period were admitted to the hospital. Crews excluded samples taken from an extremity with a crush injury, amputation, or fracture. The study period encompasses the first 18 months of implementation, during which a serum lactate has to be obtained at the initial point of contact between an air medical provider and a trauma patient.
We trained prehospital providers to use a Food and Drug Administration approved, Clinical Laboratory Improvement Amendments-waived POC serum lactate meter (Lactate Pro, FACT, Canada). This practice was operationalized through didactics, in-services, helicopter base posters, e-mail reminders, and quality assurance feedback. This device operates using a small sample of peripheral venous blood obtained during routine intravenous access. This device has low disposable costs (ϳ$1.80/sample), operates in a wide range of temperatures and humidity, and provides rapid results (60 seconds), making it useful in the prehospital environment. Blood for lactic acid analysis was sampled from peripheral venous and capillary vessels rather than central venous or arterial because of practicality. Prehospital providers were not blinded to pLA but could only alter treatment after consultation with medical command physicians after the value was reported during an online command consultation. Medical command physicians work from a separate communications center and do not participate in the care of patients in the ED or trauma bay. The receiving trauma team was blinded to the results of pLA were not made part of the patient record until the following day.
All trauma patients had automated and continuous monitoring with LIFEPAK 12 monitors (PhysioControl, Redmond, WA). After each patient transport, prehospital providers transcribe vital signs into standardized, electronic medical record (EMS Charts, West Mifflin, PA), sampling vital signs every 5 minutes of transport. Also recorded is a narrative of injury, medications administered, and change in patient condition.
From the prehospital database, the patient's demographics, date of service, vital signs, Glasgow Coma Scale (GCS) score, serum lactate concentration, and treatment were downloaded and probabilistic linkage was used to identify the in-hospital record using time and date of service. In-hospital medical records were used to record outcome information. A standardized data collection sheet was used by two investigators (J.L.C. and J.Q.) and ϳ20% of the records were abstracted by a second research assistant to determine reliability of information. Adjudication, if necessary, was performed by one investigator (F.X.G.).
The primary outcome was in-hospital death. Secondary outcomes were emergent surgery and development of MOD syndrome (MODS). 13 Emergent surgery is defined as any of the following procedures for hemorrhage control in the first 24 hours of hospitalization: thoracotomy, laparotomy, pelvic fixation, and embolization. Outcomes were selected based on previous work identifying lactate as a predictor of critical injury and illness. 14 -17 MODS was defined as the score Ͼ6 on the MOD score. MODS is the sum of the following ordinal subscales: (a) the respiratory system (PaO 2 /FIO 2 ratio); (b) the renal system (serum creatinine concentration); (c) the hepatic system (serum bilirubin concentration); (d) the hematologic system (platelet count); (e) the central nervous system (GCS); and (f) the cardiovascular system (heart rate ϫ central venous pressure/mean arterial pressure). 13 The association between the presence and absence of a significant in-hospital outcome and each potential diagnostic determinant was fist quantified using univariate logistic regression analyses. Candidate variables (age, sex, initial systolic blood pressure, heart rate, respiratory rate, and GCS were selected to be included in the initial model if they were available to a prehospital provider on initial evaluation and have a biological plausible relationship with lactic acid and/or outcomes. Determinants with significant univariate association (p Ͻ 0.20) with respective outcomes were used to build multivariable logistic regression models, presented as adjusted odds ratios with 95% confidence intervals (95% CIs). Interactions between the variables were systematically searched, and colinearity was considered when r Ͼ0.8 (Spearman coefficient matrix correlation). Discrimination of the final models with and without serum lactate was assessed by the likelihood ratio 2 statistics and the difference in the area under the receiver operator curves. Calibration of models was tested using the Hosmer-Lemeshow statistic. Cutoff values were established using common definitions of shock (shock index Ͼ0.8, heart rate Ͼ110, and systolic blood pressure Ͻ100), respiratory distress (RR Ն30), and altered sensorium (GCS score Ͻ15), and the additional value of pLA to improve sensitivity was calculated. The cutoff value of pLA of 2 mmol/L was selected because it was the point that minimized misclassification of subjects.
All data were tested for normal distribution with visual inspection of histograms and the Kolmogorov-Smirnov test. Data are presented as mean Ϯ SD or median (25-75 interquartile range [IQR]) for non-Gaussian variables. Group differences were calculated using Student's t test or MannWhitney U test for continuous variables and 2 test for ordinal variables. Analysis was performed using STATA software (version 10, STATA Inc., College Station, TX). As detailed in Table 1 , patients who died in-hospital were older, had a higher proportion of falls, and were primarily scene runs. There were more head and chest injuries and higher initial prehospital heart rates in those who died. pLA was 3. In multivariable analysis shown in Table 2 , pLA were significantly associated with increased in-hospital mortality, emergent operations, and MOD independent of potential confounders. Abnormal GCS was a strong predictor of death, but did not predict the need for emergent operation or development of MODS. pLA was the only available prehospital variable predictive of all the three outcomes. As shown in Table 3 , the addition of pLA Ͼ2 mmol/L improved the identification of patients who went on to die, need emergent operations, and develop MODS at the expense of specificity.
This study has several important limitations. The patient populations transported by our air medical service are predominantly blunt trauma victims, of higher acuity, and may not be broadly generalizable to trauma patients at large. A selection bias for high acuity patients likely exists, as minor trauma patients would be sent by ground to local facilities. Despite the high acuity of these patients, mortality was low (6%). This cohort of patients does not include patients with short flight times or patients who were in extremis. In these cases, lactate is not necessary to identify severe illness. pLA concentrations were reported to the command physician and resulted in additional fluid resuscitation at the discretion of the command physician. Although the additional resuscitation is a confounder, it would be likely that the additional early resuscitation may have improved patient outcomes. The majority of these data were obtained from venous samples but some (Ͻ10%) were acquired from capillary samples. Whether these two routes of sampling are comparable in trauma patients is unknown. We were unable to control for the time between lactate values taken on the prehospital setting and the hospital given the retrospective nature of the study.
DISCUSSION
We found that in a large cohort of prehospital patients being transported to a Level I trauma center, a single measurement of serum lactic acid at initial prehospital patient contact provides useful risk-stratification information about in-hospital morbidity and mortality. Furthermore, we demonstrated that the relationship between increased pLA and morbidity and mortality was independent of the presence of other available prehospital information, including vital signs and mental status. These observations suggest that pLA provides information that can potentially be used to inform medical decision-making to improve patient outcomes.
Hyperlactemia is a consequence of lactic acidosis and a surrogate marker for metabolic acidosis resulting from cellular hypoxia. POC lactate measurements provide a global assessment of perfusion through the quantification of cellular hypoxia. Serum lactate is a predictive of compromised perfusion and is associated with hypovolemic shock. Previous studies of the prognostic utility of serum lactate have shown that it is a predictive of poor outcomes when measured in the hospital setting. 9, 11, 18, 19 Small case series demonstrated that prehospital lactate (pLA) predicted death in a population with abnormal vital signs or GCS. 10, 20 This study suggests that lactate can be used as a prehospital triage tool to identify a group of patients at high risk of death. At least one abstract reports the use of pLA for predicting the need for hospital and intensive care unit admission. 18 This study extends previous investigations by showing that pLA can be useful for earlier identification of occult shock in trauma patients in the prehospital setting.
We think that a risk-stratification biomarker such as serum lactic acid may aid in the triage decisions to identify patients in the field who require life-saving interventions and intensive in-hospital therapy. Patients with increased pLA may benefit from triage to trauma centers, even when they have no apparent shock, respiratory distress, or altered sensorium. However, this study does not address the issue regarding titration of prehospital resuscitation. More data are required to establish whether a tool such as pLA could be used to modify prehospital therapy. For example, prehospital volume resuscitation may increase mortality, particularly in penetrating trauma, by increasing uncontrolled bleeding, pulmonary edema, and visceral edema. 21 Current concepts of damage-control resuscitation require careful selection of patients who may benefit from aggressive volume resuscitation. [22] [23] [24] Blind application of crystalloid solutions may result in dilutional coagulopathy and disruption of the glycocalyx resulting in microvascular compromise. 25, 26 In conjunction with vital signs and neurologic assessment, serum lactate may allow for the selection of a patient population who would benefit from early resuscitation while minimizing patient exposure to isotonic fluids. In contrast, other studies suggest that patients have better outcomes when systolic pressures are 4 A necessary step before using pLA to alter hospital disposition of trauma patients will be to determine whether it has a similar relationship with outcome in patients who have not been preselected for air medical transport. These data suggest that an abnormal pLA can identify eight additional patients of 100 at the risk of death, emergent surgery, or MODS who would otherwise not be identified by abnormal vital signs. pLA may be especially useful in populations of patients who's vital signs may be masked by medications or extremes of age.
In this sample, there were still 8% of subjects at the risk of death or requiring emergent interventions who had normal pLA. As the ground prehosptial crews had already designated, these cases for air medical transport, other features of the patient presentation, may have helped in decision-making. Therefore, pLA should be considered as an adjunct to increase sensitivity for detecting injury and not be advanced as a test to rule out injury. pLA may allow prehospital providers to better discern which patients require resuscitation based on an objective assessment of hypoperfusion by titrating resuscitative efforts according to more physiologic endpoints.
Our study reveals that pLA at the scene of injury provides additional prognostic information about in-hospital morbidity and mortality independent of clinically apparent shock, respiratory distress, and altered sensorium. A prospective validation in unselected trauma patients is necessary before widespread adoption of pLA by prehospital providers. Future implementation might include using pLA as part of a decision aid to identify and direct the need for aggressive prehospital and ED resuscitation.
